Back to Search Start Over

GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1.

Authors :
Taylor AM
Bailey C
Belmont LD
Campbell R
Cantone N
Côté A
Crawford TD
Cummings R
DeMent K
Duplessis M
Flynn M
Good AC
Huang HR
Joshi S
Leblanc Y
Murray J
Nasveschuk CG
Neiss A
Poy F
Romero FA
Sandy P
Tang Y
Tsui V
Zawadzke L
Sims RJ 3rd
Audia JE
Bellon SF
Magnuson SR
Albrecht BK
Cochran AG
Source :
Journal of medicinal chemistry [J Med Chem] 2022 Aug 25; Vol. 65 (16), pp. 11177-11186. Date of Electronic Publication: 2022 Aug 05.
Publication Year :
2022

Abstract

Bromodomains are acetyllysine recognition domains present in a variety of human proteins. Bromodomains also bind small molecules that compete with acetyllysine, and therefore bromodomains have been targets for drug discovery efforts. Highly potent and selective ligands with good cellular permeability have been proposed as chemical probes for use in exploring the functions of many of the bromodomain proteins. We report here the discovery of a class of such inhibitors targeting the family VIII bromodomains of SMARCA2 (BRM) and SMARCA4 (BRG1), and PBRM1 (polybromo-1) bromodomain 5. We propose one example from this series, GNE-064, as a chemical probe for the bromodomains SMARCA2, SMARCA4, and PBRM1(5) with the potential for in vivo use.

Details

Language :
English
ISSN :
1520-4804
Volume :
65
Issue :
16
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
35930799
Full Text :
https://doi.org/10.1021/acs.jmedchem.2c00662